ConditionOral Squamous Cell Carcinomas
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorCentre Leon Berard
About this trial
The goal of this project is to characterise the heterogeneity of all cell populations (tumour cells, stromal and immune microenvironment) present in the tumor and their normal (and leucoplasic) counterparts by scRNAseq in OSCC patients.
Eligibility criteria
Qualifiers
I1. Male or female at least 18 years old.
I2. Patient with OSCC and undergoing surgery at the Centre Léon Bérard.
I3. Patient who has agreed to participate in this research and sign consent.
I4. Patient affiliated to a medical insurance.
Disqualifiers
NI1. Pregnant or nursing woman.
NI2. Contraindication to general anesthesia.
NI3. Suspicion of rare tumor of particular histology other than squamous cell carcinoma (Sarcoma...).
NI4. Patient under curatorial or guardianship or placed under the protection of justice.
Trial design
Treatments tested in this trial
- Biospecimen
- Blood sampling
Treatment groups
50 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov